Zeiss Receives CE Mark for Cirrus PathFinder AI Tool with Automated OCT Assessment

Zeiss has received CE mark for the Cirrus PathFinder, a clinical support tool with AI fully integrated designed to improve decision-making and accelerate a clinician’s workflow with OCT interpretation assistance.

The Cirrus PathFinder uses proprietary deep learning algorithms to automatically identify abnormal macular OCT B-scans as a licensed element of a new Cirrus software release. It also provides AI-enhanced OCTA image quality and multi-layer segmentation, helping to improve a practice’s workflow efficiency and patient care, according to Zeiss. The technology also delivers high-speed image capture with HD imaging detail, a wide field of view, and AI decision support, helping clinicians make more informed and efficient decisions.

“With PathFinder AI Decision Support, our game-changing technology identifies OCT B-scans that may require additional review, raising our advanced diagnostic portfolio to a new level of patient care support,” said Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology. 

Other features of the Cirrus PathFinder:

• Improved clinical decision support – Without requiring export and data analysis from third-party platforms, Cirrus PathFinder’s fully integrated AI decision support algorithm interprets data within the clinician’s current workflow, allowing for the assessment of many hundreds of scans at once, in real time, upleveling the value of a clinician’s time. During image acquisition, this AI-guided workflow tool flags areas that may require more detailed imaging and, during review, allows the user to focus on what matters – improving patient care.
• Improved OCTA image quality – New Cirrus operating software provides AI-enhanced visualization of the vascular structure and B-scan averaging of the OCTA structural scans. Increased layer segmentation further enhances the user’s diagnostic capability for even more efficient decision making.
• Enhanced connectivity and security – New cybersecurity features are designed to meet ever-evolving compliance and security needs. Additionally, the Zeiss Cirrus platform ensures the seamless review of legacy OCT data combined with other diagnostic modalities to further enhance patient care. 

Cirrus PathFinder is available via license within the new Cirrus software update, which includes an expanded Reference Database (RDB) that is triple the size of the previous RDB, cybersecurity enhancements, multi-layer segmentation, and improved OCTA visualization. The software update is available in select markets. 

More information about Cirrus PathFinder can be found here.